Background-Periprocedural myocardial infarction (MI) occurs in a significant proportion of patients undergoing percutaneous coronary intervention (PCI) and portends poor outcomes. Currently, no clinically applicable method predicts periprocedural MI in the cardiac catheterization laboratory before it occurs. We hypothesized that impaired baseline coronary microcirculatory reserve, which reduces the ability to tolerate ischemic insults, is a risk for periprocedural MI and that the index of microcirculatory resistance (IMR) measured during PCI can predict occurrence of periprocedural MI. Methods and Results-Consecutive patients undergoing elective PCI of a single lesion in the left anterior descending coronary artery were recruited. A pressure-temperature sensor wire was used to measure IMR before PCI. Of the 50 patients studied, 10 had periprocedural MI. From binary logistic regression analyses of all clinical, procedural, and physiological parameters, univariable predictors of periprocedural MI were pre-PCI IMR (P=0.003) and the number of stents used (P=0.039). Pre-PCI IMR was the only independent predictor in bivariable regression analyses performed by adjusting for each available covariate one at a time (all P≤0.02). Pre-PCI IMR ≥27 U had 80.0% sensitivity and 85.0% specificity for predicting periprocedural MI (C statistic, 0.80; P=0.003). Pre-PCI IMR ≥27 U was independently associated with a 23-fold risk of developing periprocedural MI (odds ratio, 22.7; 95% CI, 3.8-133.9). Conclusions-These data suggest that the status of the coronary microcirculation plays a role in determining susceptibility toward periprocedural MI at the time of elective PCI. The IMR can predict subsequent risk of developing myocardial necrosis and may guide adjunctive prevention strategies. (Circ Cardiovasc Interv. 2012;5:515-522.)
M ore than 1 million elective percutaneous coronary intervention (PCI) procedures are performed annually worldwide. [1] [2] [3] Periprocedural myocardial infarction (MI) occurs frequently after elective PCI, and recent studies have suggested that the occurrence of periprocedural MI results in increased risk for future adverse cardiac events and mortality. 4, 5 Factors associated with periprocedural MI include patient characteristics, such as age and comorbidities; lesionrelated issues, such as plaque volume and lesion complexity; and procedural aspects, such as number of stents deployed. 6 Preexisting microcirculatory impairment may also predispose a patient to periprocedural MI. [7] [8] [9] In the absence of significant procedural complications, such as dissection or branch vessel compromise, periprocedural MI is believed to be caused by embolization of plaque debris and thrombus into the distal microcirculation during the procedure. 5 Therefore, the integrity of the distal microcirculation may affect its ability to tolerate embolic or ischemic insults during PCI. However, the role of baseline microcirculatory status for predicting periprocedural MI has not been well studied. 5, 6, 10 The index of microcirculatory resistance (IMR) is a simple guidewire-based measurement that allows quantitative assessment of the minimum microcirculatory resistance in a target coronary artery territory. 11 It is stable in the presence of varying hemodynamic conditions 12 and can predict infarct size when measured after primary PCI. 13 We hypothesized that impaired baseline microcirculatory reserve as manifested by a high IMR before PCI is a risk for periprocedural MI and that IMR measured before stenting can predict periprocedural MI.
Methods

Study Sample
Consecutive patients who fulfilled the following criteria were included: PCI performed for stable coronary disease, single target lesion with ≥50% diameter stenosis, and a Thrombolysis in Myocardial Infarction grade 3 flow. Because extent of microcirculatory disruption depends on the size of myocardial territory supplied, only patients with lesions in the proximal or mid segment of the left anterior descending coronary artery were recruited. Patients with recent MI (baseline troponin levels more than the 99th percentile) and prior MI in the target territory were excluded because baseline IMR may be elevated in these settings. Patients who underwent concomitant PCI of a side branch were also excluded because it might result in embolization down the side branch and an increased troponin level without change in IMR.
Patients were deemed to have comorbidities, including diabetes, hypertension, and hyperlipidemia, if these were previously diagnosed by their physician or if the patients were receiving treatment for these conditions. Family history was considered positive if a first-degree relative was given a diagnosis of coronary artery disease at age ≥60 years. Cigarette smokers were patients who were current smokers or had ceased smoking within 1 year of recruitment. Patients were considered to have renal impairment when their estimated glomerular filtration rate was ≤60 mL/min per 1. The study was approved by the human research ethics review boards of both study institutions. Written informed consent was obtained from all participants.
Coronary Physiology Measurements
For the procedure, a 6F femoral arterial sheath and a 5F femoral venous sheath were inserted. Unfractionated heparin was administered in all patients (100 U/kg in those who did not receive glycoprotein IIb-IIIa inhibitors and 60-70 U/kg in those who did). Coronary physiology measurements were performed before PCI as previously described. [12] [13] [14] In brief, a 6F angioplasty guiding catheter without side holes was first used to engage the left main coronary artery. A pressure-temperature sensor guidewire (Certus Pressure Wire; St Jude Medical) was used for physiology measurements and PCI. Pressure measurement from the wire was first equalized with that of the guiding catheter. The lesion was crossed, and the pressure sensor was positioned two thirds of the way down the artery, at least 3 cm beyond the lesion. Intracoronary nitroglycerin was administered (100-200 μg). To derive mean transit time at rest (T mnR ), thermodilution curves were obtained by 3 injections of 3 mL of room temperature saline down the coronary artery. Hyperemia was induced using adenosine infusion (140 μg/kg per minute) through the femoral sheath. Proximal arterial pressure (P a ), distal arterial pressure (P d ), and mean transit time during hyperemia (T mnH ) were recorded. As previously described, fractional flow reserve was calculated by mean P d /P a during hyperemia, and coronary flow reserve was calculated by T mnR / T mnH . 12 Patients then underwent PCI, and the coronary wedge pressure (P w ) was recorded during first balloon inflation. Collateral flow index was calculated by P w /P a .
In most previous studies involving clinical application of IMR, the IMR was measured in the absence of significant epicardial disease or after treatment of the coronary stenoses. 13, 15 This allowed for the use of the simplified formula, which does not account for collateral flow (IMR uncorrected =P d ×T mnH ). However, in the presence of significant epicardial stenoses, as in the present patient cohort, true microcirculatory resistance will be overestimated by this formula.
14 Incorporating P w to account for collateral flow (IMR=P a ×T mnH ×[P d −P w ]/[P a −P w ]) allows for accurate measurement of the IMR despite significant epicardial stenosis, 14 and this method was used to derive IMR in the current study. The IMR was measured before and after PCI.
Quantitative Coronary Angiography
Percentage diameter stenosis, minimum luminal diameter, vessel size, and lesion length were measured using quantitative coronary angiography as previously described. 16 Cine images were acquired at 15 frames/s (Axiom Artis; Siemens). Quantitative coronary angiography was performed offline using the CAAS (Cardiovascular Angiography Analysis System) II (Pie Imaging). Automated distance calibration was used to determine pixel size. Angiographic views with the least foreshortening and yielding the best depiction of the stenoses were used. Measurements were performed twice and averaged.
Measurement of Cardiac Enzymes
As per specific institutional protocols, creatine kinase level was collected in all patients, whereas a troponin T assay was performed in one institution, and troponin I assay was performed in the other. All assays were performed by the general biochemistry laboratories of the 2 institutions. Creatine kinase and troponin T levels were measured using the Modular Analytics System (Roche) in one institution, whereas creatine kinase and troponin I levels were measured using the Dimension RxL Max Integrated Chemistry System (Siemens Healthcare Diagnostic) in the other. Blood was collected for post-PCI cardiac enzyme level measurement on average 18.0±2.8 hours after PCI. There currently is no solid scientific basis for defining a biomarker threshold for the diagnosis of periprocedural MI. 5 In this study, periprocedural MI was defined as a post-PCI troponin level >10 times the 99th percentile (>0.10 μg/L for troponin T or >0.70 ng/mL for troponin I) because these thresholds have been shown to be of prognostic significance in previous studies. 17, 18 Pre-PCI IMR was also tested for its ability to detect MI based on the universal definition (post-PCI troponin >3 times the 99th percentile). 19 Significant elevation in creatine kinase level was defined as creatine kinase >2 times the 99th percentile.
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Statistical Analysis
To determine whether pre-PCI IMR can detect periprocedural MI, 50 patients from 2 tertiary referral institutions were recruited for this study. A previous study that used IMR as a marker of microcirculatory impairment demonstrated an absolute difference in IMR of 9 U between patients who underwent direct stenting versus patients who received balloon predilation before stenting. 15 Using an estimated periprocedural MI rate of 33% based on a previous meta-analysis 4 
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and a pre-PCI IMR difference of 8 U between patients who develop periprocedural MI and those who do not, with an SD of 10 U in both groups, a total number of 50 patients were required to achieve 80% power and a 2-sided level of significance of 0.05.
Results are expressed as mean±SD, unless otherwise stated. To compare patients who developed periprocedural MI with those who did not, independent t tests were used to compare means for continuous variables, and Fisher exact tests were used for categorical variables. Continuous variables that did not follow a normal distribution were compared using Mann-Whitney tests. The association between IMR and baseline clinical characteristics were assessed by using correlation analyses (Spearman or Pearson where appropriate) for continuous variables and independent t tests for dichotomous variables by comparing the mean IMR between the groups with and without the clinical characteristic in question.
Variables were tested for their predictive ability using univariable binary logistic regression analysis. To assess for the significance of IMR after adjustment for baseline covariates, bivariable regression analyses were performed by adjusting for each available covariate one at a time in separate analyses because the number of outcome events were low. Receiver operating characteristic analysis was used to determine the optimum IMR cutoff to predict periprocedural MI. All formal statistical analyses were performed only after recruitment was completed, using ACCorD (Analysis of Censored and Correlated Data Software) version 1.7.0 (Boffin Software) and SAS version 9.1 (SAS Institute) software. Figures and graphs were generated using Prism version 5.01 (GraphPad) software. A 2-tailed P<0.05 was considered significant.
Results
Clinical Characteristics
Pre-PCI coronary physiology measurements of a representative patient are shown in Figure 1 . Baseline clinical, procedural, and coronary physiology data of patients with and without periprocedural MI are shown in Table 1 . Of the 50 patients studied, 10 (20.0%) had periprocedural MI. No patient had dissection or target vessel closure, and no patient had branch vessel compromise at the end of the procedure. No patient had significant hypotension or arrhythmias immediately after PCI. Two patients had slow flow after stenting, both of whom had a TIMI (Thrombolysis in Myocardial Infarction) grade 3 flow after institution of adjunctive therapy, and both developed MI. There were 22 patients (44.0%) with proximal lesions and 28 (56.0%) with mid lesions. There were 31 patients (62.0%) with American College of Cardiology/American Heart Association type A lesions and 19 (38.0%) with type B lesions. There were no significant differences between the 2 institutions in post-PCI cardiac enzyme levels as well as number of patients with periprocedural MI based on the various enzyme cutoff levels (online-only Data Supplement Table I ).
IMR and Its Association With Clinical Characteristics
The mean IMR was 20.4±11.5 U. Patients receiving statin therapy had lower IMR compared with those who were not (18.9±11.0 versus 28.3±11.7 U, P=0.03). There were no other significant associations between IMR and other baseline clinical characteristics or medication use.
Pre-PCI IMR To Predict Periprocedural MI
Troponin levels were less than the 99th percentile in all patients before PCI. Post-PCI cardiac enzyme levels were higher in the group who developed periprocedural MI com- Patients with periprocedural MI had a significantly higher pre-PCI IMR compared with patients without MI (31.6±11.8 versus 17.6±9.7 U, P<0.001) (Figure 2 ). Among all baseline clinical, procedural, and coronary physiology variables listed in Table 1 To interrogate the interaction between number of stents and IMR, the cohort was stratified based on the number of stents deployed. Regardless of whether 1 stent or >1 stent was deployed, the IMR tended to be higher in patients who developed MI. In a model that includes only pre-PCI IMR and number of stents, the association with periprocedural MI remained significant for pre-PCI IMR (P=0.013) but not for number of stents (P=0.157).
The best IMR cutoff to predict periprocedural MI was IMR ≥27 U, with a sensitivity of 80.0% and a specificity of 85.0% (C statistic, 0.80; P=0.003) (Figure 3) . When used as a binary variable, IMR ≥27 U was associated with a 23-fold increased odds of developing periprocedural MI (OR, 22.7; 95% CI, 3.8-133.9; P=0.001), and IMR ≥27 U remained a significant independent predictor of periprocedural MI in every bivariable regression model where each available covariate was adjusted for separately one at a time (all P≤0.002). Patients with a baseline IMR ≥27 U had a 57% incidence of periprocedural MI, and patients with an IMR <27 U had a 5.5% incidence of periprocedural MI.
The utility of IMR to predict periprocedural MI as defined by the universal definition of periprocedural MI (post-PCI troponin level >3 times the 99th percentile) was also assessed. 19 Fourteen patients in the present study developed periprocedural MI according to this definition. Pre-PCI IMR was also a univariable predictor of periprocedural MI based on this definition (OR, 1.06 for every 1-U increase of IMR; 95% CI, 1.01-1.13; P=0.036).
Based on an older creatine kinase-based definition for MI, 20 4 patients developed post-PCI creatine kinase levels >2 times the 99th percentile. Patients with post-PCI creatine kinase levels >2 times the 99th percentile had higher pre-PCI IMR than those with post-PCI creatine kinase levels ≤2 times the 99th percentile (35.0±3.6 versus 19.0±11.0 U, P=0.01). In patients with post-PCI creatine kinase elevation more than the 99th percentile (n=7), pre-PCI IMR correlated with post-PCI creatine kinase levels (r=0.79, P=0.033). Post-PCI coronary physiology measurements are shown in Table 2 . Pre-PCI IMR correlated with post-PCI IMR (r=0.41, P=0.005). Although the absolute post-PCI IMR value was higher in patients who developed periprocedural MI than in those who did not have MI, this difference was 
Discussion
The main finding of this study is that elevated baseline IMR, which reflects impaired microcirculatory integrity before PCI, is predictive of developing PCI-related myocardial necrosis. In patients undergoing elective left anterior descending artery stenting, a pre-PCI IMR ≥27 U was independently associated with a 23-fold increased risk of developing periprocedural MI and identified a group of patients who had a very high incidence (57%) of subsequent periprocedural MI. These findings suggest that the status of the microcirculation plays an important role in determining vulnerability toward embolic or ischemic insults arising as a consequence of PCI. Furthermore, by identifying patients at high risk for subsequent myocardial necrosis, pre-PCI IMR may guide adjunctive strategies to prevent periprocedural MI.
Association Between Microcirculatory Status and Periprocedural MI
MI as a result of PCI can be caused by branch or main vessel compromise or due to structural and functional microvascular obstruction in the distal bed. 5 The latter is believed to account for 50% to 70% of MIs related to PCI. 5 During PCI, atheromatous plaque may be dislodged, leading to embolization of debris, thrombus, microparticles, and active peptides. 5, 21 Existing microcirculatory impairment may predispose toward plugging or attenuated clearing of embolized material and, therefore, increase susceptibility toward developing periprocedural MI. The present study of a cohort of patients without main or branch vessel closure supports this hypothesis.
A previous study found an association between increased Doppler-derived microcirculatory resistance and post-PCI troponin I elevation. 7 However, resistance was measured when there was only collateral flow through the target myocardium during balloon occlusion, and it is unclear how this actually relates to resistance during native coronary flow. Moreover, the variables examined in this previous study were not tested in a multivariate model. The current study confirms that microcirculatory resistance, measured during native coronary flow, is a determinant of susceptibility toward periprocedural MI and suggests that the IMR can be used as a tool to risk stratify patients before PCI.
Other Factors Predisposing Toward Periprocedural MI
Many variables have been previously identified as potential risk factors for periprocedural MI, including age, female sex, family history, diabetes, dyslipidemia, hypertension, smoking, body mass index, renal impairment, lack of glycoprotein IIbIIIa use, and predilation.
5,10 These factors were not significantly predictive in the present study possibly because of the selective nature of the cohort and small sample size. The results confirmed previous observations that an increased number of stents deployed is associated with periprocedural MI. 22 There were nonsignificant trends toward greater amounts of contrast used, number of American College of Cardiology/American Heart Association type B lesions, total stent length, and total inflation time in patients who developed MI compared with those who did not. This is consistent with the fact that lesion complexity is associated with occurrence of periprocedural MI. 5 In the current study, pre-PCI IMR was shown to be an independent predictor of periprocedural MI, even after all these variables were considered. Moreover, there were no significant associations found between these variables and pre-PCI IMR.
It is uncertain why there was a trend in the present cohort toward a higher rate of preprocedural clopidogrel use in patients who developed periprocedural MI than in those who did not (Table 1) , and this may have been a chance association. Importantly, there was no association between clopidogrel use and pre-PCI IMR that may have confounded the results of this study.
The DEBATE (Doppler Endpoints Balloon Angioplasty Trial Europe) II study showed that post-PCI coronary flow velocity reserve was predictive of periprocedural MI and correlated with the pre-PCI coronary flow velocity reserve. 8 However, a direct association between pre-PCI coronary flow velocity reserve and periprocedural MI was not shown. 8 The results of the current study demonstrate that preprocedural coronary flow reserve was not predictive of periprocedural MI, 8 which is probably because coronary flow reserve not only is indicative of the status of the microcirculation, but also will be affected by epicardial stenoses, which were present in the current patient cohort. 12 Recent studies performed by our group and others confirmed that in the absence of periprocedural MI, the IMR remains the same pre-and post-PCI, 23, 24 demonstrating that the IMR provides a specific assessment of the coronary microcirculation independent of the epicardial vessel. The IMR also depends less on hemodynamic conditions compared with the coronary flow reserve and, therefore, is more useful in this setting. 12 The findings from the present study agree with previous data demonstrating that angiographic measures of plaque severity, such as minimum luminal diameter and lesion length, were not predictive of periprocedural MI. 25 Features of the atheroma, including plaque burden assessed by intravascular ultrasound 25 and thin cap fibroatheroma assessed by optical coherence tomography, 26 have been shown to be predictive of periprocedural MI. Intravascular imaging was not performed in the present study. However, the strong association shown between IMR and periprocedural MI supports the role of the microcirculation in determining periprocedural MI susceptibility independent of lesion characteristics.
Post-PCI fractional flow reserve of the present cohort was somewhat lower than that obtained by previous studies. 27 This may be due to residual diffuse coronary disease. It is reassuring that there was no association between post-PCI fractional flow reserve and occurrence of periprocedural MI.
Association Between IMR and Statin Use
Patients taking statins had lower IMR than those who were not taking statins. Previous studies have shown benefit in the use of statins in preventing PCI-related MI, 28 and this was previously hypothesized to be secondary to plaque stabilization. 5 Statins have been shown to attenuate hypoxia-induced nitric oxide synthase inhibition in human microvascular endothelial cells and improve coronary vasodilator reserve in patients with early coronary disease. 29, 30 The present study supports the hypothesis that statins improve coronary microvascular function and suggests that statins protect against periprocedural MI at least in part because of effects on the microcirculation.
Definition and Significance of Periprocedural MI
Various cutoff values have been previously used to define periprocedural MI, 5, 19 and there is lack of data to substantiate the use of an arbitrary cutoff level to define periprocedural MI as per the universal definition of MI. 19 Moreover, there is no universal consensus on thresholds that predict adverse outcomes. 6, 10 The cutoff values for troponin and creatine kinase used in the current study were chosen because they have been shown to be of prognostic significance. 17, 18, 20 When the threshold of enzyme elevation to define periprocedural MI was lowered to >3 times the 99th percentile, IMR remained an independent predictor, suggesting that it is a sensitive method to detect susceptibility toward periprocedural MI. Pre-PCI IMR was also associated with occurrence of larger infarcts as defined by post-PCI creatine kinase levels of >2 times the 99th percentile. 20 Two recent meta-analyses demonstrated that an elevated cardiac troponin level after PCI is associated with increased risk of future adverse cardiac events and death. 4, 31 However, there is debate about whether such troponin elevations are simply associated with underlying comorbidities that cause the increased risk of future events or whether myocardial necrosis due to the procedure itself results in adverse outcomes. 6, 10 We believe that the IMR could potentially be used to select an enriched population at high risk of developing periprocedural MI in trials of adjunctive therapies aimed at improving outcomes.
Study Limitations
Limitations of this study include the relatively small sample size, and larger studies will be necessary to determine whether IMR can predict clinical outcomes. Our study included only proximal or mid-left anterior descending coronary artery lesions to allow for control of the territorial extent of coronary microcirculatory disruption as a potential confounding variable. This strict inclusion criterion facilitated the identification of a pre-PCI IMR cutoff value to predict periprocedural MI in a relatively small study cohort. However, although the principle of impaired microcirculatory reserve being a substrate for periprocedural MI can be generalized to the other epicardial arteries, further studies will be required to define IMR cutoff values for arteries other than the left anterior descending coronary artery. There were relatively few patients who developed periprocedural MI. However, the sensitivity analysis confirmed that the predictive models obtained were robust. Creatine kinase-MB fraction was not part of the study protocol and was not measured in this study. However, recent consensus statements indicate that measuring troponin levels is a valid method to detect periprocedural MI. 19 None of the patients had major procedural complications, such as main vessel or branch vessel compromise, that are associated with periprocedural MI, and the pre-PCI IMR is unlikely to predict such occurrences.
Conclusions
The results of this study suggest that the status of the coronary microcirculation plays an important role in determining susceptibility toward periprocedural MI. Patients with impaired microcirculatory integrity before PCI have a higher propensity for periprocedural MI. IMR may predict risk of subsequent myocardial necrosis and may guide adjunctive strategies to prevent periprocedural MI.
